Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Prednisolone for Thyroid Function Control in Graves' Disease
jRCT1041260106Recruiting
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone in Graves' disease (2 arms). Primary endpoint: Percentage change in FT3. Started Aug 2026; status: recruiting.
02
Drugs
prednisolone
03
Conditions
Graves' disease
Beyond the preview
Go deeper on jRCT1041260106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260106.